Raffi Gugasyan



Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Comment / Debate
Comment / Debate

Correction: Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics (Cancer Cell (2016) 30(3) (499–500) (S1535610816000350) (10.1016/j.ccell.2016.01.006))

Lalaoui, N., Hänggi, K., Brumatti, G., Chau, D., Nguyen, N. Y. N., Vasilikos, L., Spilgies, L. M., Heckmann, D. A., Ma, C., Ghisi, M., Salmon, J. M., Matthews, G. M., de Valle, E., Moujalled, D. M., Menon, M. B., Spall, S. K., Glaser, S. P., Richmond, J., Lock, R. B., Condon, S. M. & 10 others, Gugasyan, R., Gaestel, M., Guthridge, M., Johnstone, R. W., Munoz, L., Wei, A., Ekert, P. G., Vaux, D. L., Wong, W. W. L. & Silke, J., 12 Sep 2016, In : Cancer Cell. 30, 3, p. 499-500 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

10 Citations (Scopus)

c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells (The Journal of Experimental Medicine (December 21, 2009) 206, 13 (3001-3014))

Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G. F., Wilkinson, N., Banerjee, A., Proietto, A. I., Gugasyan, R., Wu, L., McNally, A., Steptoe, R. J., Thomas, R., Shannon, M. F. & Gerondakis, S., 12 Apr 2010, In : Journal of Experimental Medicine. 207, 4, p. 899 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

1 Citation (Scopus)